gbr 12935 has been researched along with MPTP Neurotoxicity Syndrome in 3 studies
1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine : An N-alkylpiperazine that consists of piperazine bearing 2-(benzhydryloxy)ethyl and 3-phenylpropyl groups at positions 1 and 4 respectively. Potent and selective inhibitor of dopamine uptake (KD = 5.5 nM in rat striatal membranes).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hébert, G | 1 |
| Mingam, R | 1 |
| Arsaut, J | 1 |
| Dantzer, R | 1 |
| Demotes-Mainard, J | 1 |
| Callier, S | 1 |
| Morissette, M | 1 |
| Grandbois, M | 1 |
| Di Paolo, T | 1 |
| Pai, KS | 1 |
| Ravindranath, V | 1 |
3 other studies available for gbr 12935 and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
A role of IL-1 in MPTP-induced changes in striatal dopaminergic and serotoninergic transporter binding: clues from interleukin-1 type I receptor-deficient mice.
Topics: Analysis of Variance; Animals; Dopamine Plasma Membrane Transport Proteins; Gene Expression Regulati | 2005 |
Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carrier Proteins; Corpus Striatum; Dopamine; Dopamine Plasm | 2000 |
Protection and potentiation of MPTP-induced toxicity by cytochrome P-450 inhibitors and inducer: in vitro studies with brain slices.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Cytochrome P-450 Enzyme Inhibitors; Cy | 1991 |